Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R0XE
|
||||
Former ID |
DNC013153
|
||||
Drug Name |
2-acetyl-3-hydroxycyclohex-2-enone
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C8H10O3
|
||||
Canonical SMILES |
CC(=O)C1=C(CCCC1=O)O
|
||||
InChI |
1S/C8H10O3/c1-5(9)8-6(10)3-2-4-7(8)11/h10H,2-4H2,1H3
|
||||
InChIKey |
YKOOMGHHVDVJAY-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 4-hydroxyphenylpyruvate dioxygenase | Target Info | Inhibitor | [1] | |
KEGG Pathway | Ubiquinone and other terpenoid-quinone biosynthesis | ||||
Tyrosine metabolism | |||||
Phenylalanine metabolism | |||||
Metabolic pathways | |||||
References | |||||
REF 1 | Bioorg Med Chem Lett. 2006 Dec 1;16(23):6024-7. Epub 2006 Sep 18.Enzyme inhibition potency enhancement by active site metal chelating and hydrogen bonding induced conformation-restricted cyclopropanecarbonyl derivatives. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.